Severe Aplastic Anemia (SAA) Clinical Trial
Official title:
A Description of the Oral Microbiome of Patients With Severe Aplastic Anemia
Background:
- This research is being done to describe the types of bacteria found in the mouths of
patients who have severe aplastic anemia (SAA) and are treated with drugs that suppress the
immune system or with stem cell transplant. People with SAA who receive these treatments are
more likely to get infections. Studies show that there might be a link between the bacteria
in your mouth and those bacteria that can cause infections. The bacteria found in the mouths
of patients with SAA will be described.
Objectives:
- To understand the changes in mouth bacteria that are related to treatment and to describe
the oral bacterial environment.
Eligibility:
- Adults at least 18 years of age who are going to be treated for SAA.
- Healthy volunteers at least 18 years of age.
Design:
- Participants will answer questions about their medical history and dental care. Their
mouths will be examined.
- Participants with SAA will be tested during treatment for their disease, over the course
of 1 year. All participants with SAA will be tested at 3 scheduled appointments. Any
participants who require a breathing tube will receive additional tests.
- Healthy volunteers will be tested during 1 visit.
- Participants will give two samples each time. A saliva sample will be taken with a
disposable padded tool. Skin cells will be collected from the tongue with a small
plastic brush.
The mouth is a complex biological ecosystem normally containing over 700 different species of bacteria. Some of these bacteria live in an exopolysacchride matrix biofilm and occupy specific niches in this complex oral environment. Understanding the oral environment and the microbiota that inhabit it will assist in determining their impact on health and disease. There are several studies in critically ill patients demonstrating changes in oral bacteria related to acute illness. Identification of respiratory pathogens in the mouth has led researchers to hypothesize that a relationship exists between the oral cavity and pulmonary infections. This descriptive study will characterize the oral microbiota of patients who have severe aplastic anemia (SAA). Patients will be followed for 1 year after treatment for development of respiratory symptoms that require intubation. A difference in the oral microbiome will be identified in specimens collected before and after treatment. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT04328727 -
Combination of Eltrombopag With Immunosuppressive Therapy in East-Asian Patients With Severe Aplastic Anemia
|
Phase 2 | |
Completed |
NCT00604201 -
Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodysplastic Syndrome
|
Phase 2 | |
Completed |
NCT01891994 -
Extended Dosing With Eltrombopag for Severe Aplastic Anemia
|
Phase 2 | |
Completed |
NCT00001626 -
Comparing Therapies for the Treatment of Severe Aplastic Anemia
|
Phase 2 | |
Recruiting |
NCT04409080 -
REGN7257 in Adult Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive Therapy
|
Phase 1/Phase 2 | |
Recruiting |
NCT03520647 -
Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis
|
Phase 2 | |
Withdrawn |
NCT05323617 -
Efficacy of Romiplostim in Treatment of SAA in Adults Previously Untreated With or Refractory to Immunosuppressive Therapy
|
Phase 2 |